Can you walk me through the process of how my care team will evaluate the risks and benefits of cisplatin...

I'll help explain how your care team typically evaluates cisplatin chemotherapy for colorectal cancer patients.

According to the NCCN Clinical Practice Guidelines in Oncology for Colon Cancer, your care team will consider several key factors:

1. Disease Assessment:

• Stage and location of your cancer
• Previous treatments received
• Molecular testing results (like MSI/MMR status)

1. Personal Health Factors: The American Society of Clinical Oncology (ASCO) guidelines emphasize evaluating:

• Kidney function (cisplatin can affect kidneys)
• Hearing status (potential hearing loss risk)
• Overall performance status
• Age and other medical conditions
• Heart health

1. Risk vs. Benefit Analysis: According to the National Cancer Institute (NCI), your team will consider:

• Expected survival benefit for your specific cancer stage
• Quality of life impacts
• Your personal goals and preferences
• Alternative treatment options

Your care team should discuss:

• Expected side effects
• Treatment schedule
• Monitoring plan
• Supportive care options

Important note: This evaluation process is highly individualized. Your oncologist will work with you to determine if cisplatin is the best choice for your specific situation. Always share any concerns or questions you have during these discussions.

Remember: This is a general overview based on guidelines. Your actual evaluation process may vary based on your specific circumstances and your treatment center's protocols.